Europe Anti-Infective Agents Market Forecast to 2028

Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)

Report Code : BMIRE00025824 | Region : Europe | Industry : Pharmaceuticals | Published Date : 12/Sep/2022

The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and is projected to reach US$ 49,527.90 million by 2028. It is expected to grow at a CAGR of 3.0% during the forecast period.

Increasing government support for research activities and clinical trials is driving the Europe anti-infective agents market substantially. The clinical trials industry has seen exceptional growth in the last 10 years. The FDA awarded grants through the Orphan Products Clinical Trials Grants Program, which Congress funds to promote the clinical development of medical foods, biologics, drugs, and medical devices to treat rare diseases. Grants are intended to considerably contribute to the marketing approval of products to treat rare diseases and provide essential data for developing such products. For clinical trials of possibly life-changing treatments for patients with rare diseases, the FDA has been offering much-needed financial support for more than 35 years. In addition, the Orphan Products Clinical Trials Grants Program's contributions have supported research that will lead to the marketing approval of treatments for rare diseases in the near future.

COVID-19 Vaccines are developing significantly because more participants are focusing on clinical trials and collaborating to make certain rapid growth and sufficient production capacity. In addition, the UK government has committed to providing US$ 99.9 million (£84 million) in funding and manufacturing support to researchers to work on the COVID-19 vaccine program. Hence, government funding for research activities and clinical trials is aiding the development of new therapies, thereby boosting the anti-infective agent market.

Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the Europe anti-infective agents market at a good CAGR during the forecast period.

Europe Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

Europe Anti-Infective Agents Market Segmentation

The Europe anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.

Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.

Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.

Based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is expected to hold the largest market share by the end of 2022.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the Europe anti-infective agents market.

At 3.0% CAGR, the Europe Anti-Infective Agents Market is speculated to be worth US$ 49,527.90 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Europe anti-infective agents market was valued at US$ 45,331.11 million in 2022 and is expected to reach US$ 55,179.54 million by 2028, registering an annual growth rate of 3.3% from 2022 to 2028. Increasing prevalence of chronic diseases and surging government support for research activities including clinical trials are the critical factors attributed to the market expansion.

Chronic diseases are conditions that develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral variables. The four primary categories of NCD are diabetes, cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma), and cardiovascular disorders (including heart attacks and stroke). The rising prevalence of anti-infective resistance, which has now become a public health issue, poses a hazard to human health. Antibacterial, antiviral, antifungal, and antiparasitic drugs are examples of anti-infectives, which work to prevent or treat infections. Antibiotics are chemically derived antimicrobial medications that cure and prevent bacterial illnesses by eradicating or preventing their growth. Azithromycin, clarithromycin, and erythromycin are examples of macrolides, which have historically been the main antibiotic classes, studied for their potential role in the secondary prevention of coronary heart diseases.

The study of cancer genesis has advanced to the cellular and molecular levels due to the rapid growth of contemporary science and technology, particularly biomedicine, in the 20th century. Modern cell biology describes malignancies as a group of biological illnesses distinguished by aberrant cell proliferation. Since every cancer begins in a single cell, cancers are also diseases that include alterations in the structure and function of genetic material. Since cancer cells proliferate, they pass on their malignant activity to their offspring (DNA). In the meantime, cancer formation and incidence are also promoted by the invasive growth and spread of cancer cells. One of the most significant classes of antibiotics with their unique inhibitory effects on malignancies is the anti-cancer class. The antiproliferative, pro-apoptotic, and anti-epithelial-mesenchymal-transition (EMT) properties of several antibiotics have been employed in the treatment of cancer. Thus, the increasing prevalence of chronic diseases is driving the Europe anti-infective agents market.

On the contrary, emergence of anti-infective drugs resistance and their various side effects hurdles the growth of Europe anti-infective agents market.

Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment held the largest market share of 47.2% in 2022 with a revenue of US$ 19,546.87 million. Further, it is going to reach US$ 23,105.57 million by 2028 at decent CAGR of 2.8% during the forecasted period.

Based on range, the anti-infective agents market sphere is bifurcated into broad spectrum and narrow spectrum. The former held 62.9% market share in 2022, amassing US$ 26,067.32 million. It is projected to garner US$ 30,800.55 million by 2028 to expand at 2.8% CAGR during 2022–2028.

Based on route of administration, the market is segmented into topical, oral, IV, and others. With 51.3% share IV segment dominated the market in 2022. It accrued US$ 21,254.42 million in 2022 and is estimated to reach by US$ 25,118.48 million by 2028 at a CAGR of 2.8% during 2022-2028.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. The others segment held the largest market share of 45.1% in 2022 with a revenue of US$ 18,707.76 million. Further, it is going to reach US$ 22,699.02 million by 2028 at decent CAGR of 3.3% during the forecasted period.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. With 45.0% share of the domain, the hospital pharmacies segment dominated the market in 2022. It accrued US$ 18,669.36 million in 2022 and is estimated to generate US$ 22,424.47 million by 2028 to grow at a CAGR of 3.1% over the forecast period.

Our country analysis states that Germany captured 22.3% market share in 2022. It was assessed at US$ 9,249.99 million in 2022 and is likely to hit US$ 11,169.68 million by 2028, exhibiting a CAGR of 3.2% during the forecast period.

Key players dominating the Europe anti-infective agents market are Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG among others.

Few of the recent key developments among the top market players are listed below:

In April 2021, Abbott launched adult vaccination program for flu, typhoid, and more vaccines to safeguard people's health. The program aimed to create awareness regarding immunization in adult populations. In January 2021, Merck confirmed an agreement with UNICEF to establish the world’s first global Ebola vaccine stockpile with ERVEBO® (Ebola Zaire Vaccine, Live). ERVEBO is a vaccine indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Anti-Infective Agents Market – By Type

1.3.2 Europe Anti-Infective Agents Market – By Range

1.3.3 Europe Anti-Infective Agents Market – By Route of Administration

1.3.4 Europe Anti-Infective Agents Market – By Indication

1.3.5 Europe Anti-Infective Agents Market – By Distribution Channel

1.3.6 Europe Anti-Infective Agents Market – By Country

2. Europe Anti-Infective Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Anti-infective agents Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Anti-Infectives Agents Market – Key Market Dynamics

5.1 Key Drivers

5.1.1 Chronic Diseases Rising

5.1.2 Increasing Government Support for Research Activities and Clinical Trials

5.2 Market Restraints

5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects

5.3 Market Opportunities

5.3.1 Upcoming of New Anti-infective Agents

5.4 Future Trends

5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector

5.5 Impact Analysis

6. Anti-Infectives Agents Market – Europe Analysis

6.1 Europe Anti-Infectives Agents Market Revenue Forecast and Analysis

7. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type

7.1 Overview

7.2 Europe Anti-infectives Agents Market, by Type, 2022 & 2028 (%)

7.3 Anti-Viral

7.3.1 Overview

7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)

7.4 Anti-Bacterial

7.4.1 Overview

7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)

7.5 Anti-Fungal

7.5.1 Overview

7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range

8.1 Overview

8.2 Europe Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)

8.3 Narrow Spectrum

8.3.1 Overview

8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)

8.4 Broad Spectrum

8.4.1 Overview

8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration

9.1 Overview

9.2 Europe Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)

9.3 IV

9.3.1 Overview

9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)

9.4 Oral

9.4.1 Overview

9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)

9.5 Topical

9.5.1 Overview

9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication

10.1 Overview

10.2 Europe Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Tuberculosis

10.4.1 Overview

10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Respiratory Infection

10.5.1 Overview

10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)

10.6 Pneumonia

10.6.1 Overview

10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel

11.1 Overview

11.2 Europe Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)

11.3 Hospital Pharmacies

11.3.1 Overview

11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.4 Retail Pharmacies

11.4.1 Overview

11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.5 Specialty Pharmacies

11.5.1 Overview

11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.6 E-Commerce

11.6.1 Overview

11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis

12.1 Overview

12.1.1 Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)

12.1.1.1 Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.1 Overview

12.1.1.1.2 Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.3 Germany: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.1.4 Germany: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.1.5 Germany: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.1.6 Germany: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.1.7 Germany: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.2 UK: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.1 Overview

12.1.1.2.2 UK: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.3 UK: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.2.4 UK: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.2.5 UK: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.2.6 UK: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.2.7 UK: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.3 France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.1 Overview

12.1.1.3.2 France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.3 France: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.3.4 France: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.3.5 France: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.3.6 France: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.3.7 France: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.4 Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.4.1 Overview

12.1.1.4.2 Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.4.3 Italy: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.4.4 Italy: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.4.5 Italy: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.4.6 Italy: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.4.7 Italy: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.5 Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.5.1 Overview

12.1.1.5.2 Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.5.3 Spain: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.5.4 Spain: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.5.5 Spain: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.5.6 Spain: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.5.7 Spain: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.6 Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.6.1 Overview

12.1.1.6.2 Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.6.3 Rest of Europe: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.6.4 Rest of Europe: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.6.5 Rest of Europe: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.6.6 Rest of Europe: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.1.6.7 Rest of Europe: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

13. Anti-infectives Agents Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022

13.3 Organic Developments

13.3.1 Overview

13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022

13.4 Inorganic Developments

13.4.1 Overview

13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14. Anti-Infectives Agents Market- Company Profiles

14.1 Abbott

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Allergan Plc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Merck & Co., Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bayer AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Bristol-Myers Squibb Company

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Boehringer Ingelheim International GmbH

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 F. HOFFMANN-LA ROCHE LTD.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Gilead Sciences, Inc.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 GlaxoSmithKline plc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Novartis AG

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Germany Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Germany Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             UK Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             UK: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 8.             UK Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          France: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 13.          France Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15.          France Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Italy Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Italy: Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Italy Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Italy Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Spain Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Spain: Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Spain Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Spain Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Spain Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Rest of Europe Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of Europe: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of Europe Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Rest of Europe Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Rest of Europe Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Recent Inorganic Growth Strategies In The Anti-infective agents Market

Table 32.          Glossary of Terms, Europe Anti-infectives Agents Market

LIST OF FIGURES.

Figure 1.           Europe Anti-Infective Agents Market Segmentation

Figure 2.           Europe Anti-Infective Agents Market Segmentation, by Country

Figure 3.           Europe Anti-infective agents Market Overview

Figure 4.           Anti-Viral Segment Held Largest Share of Product Segment in Europe Anti-Infective Agents Market

Figure 5.           France is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Anti-infectives agents Market– Revenue Forecast and Analysis – 2019 - 2028

Figure 10.        Europe Anti-infectives Agents Market, by Type, 2022 & 2028 (%)

Figure 11.        Europe Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)

Figure 16.        Europe Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)

Figure 19.        Europe IV Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Oral Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Topical Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)

Figure 24.        Europe HIV Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Pneumonia Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)

Figure 30.        Europe Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Europe Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Europe Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Europe E-Commerce Market Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Europe Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Europe: Anti-infectives Agents Market, by Key Country – Revenue (2022) (US$ Million)

Figure 36.        Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)

Figure 37.        Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Growth Strategies In The Anti-infective agents Market, 2018-2022

Figure 43.        Recent Organic Growth Strategies In The Anti-infective agents Market

The List of Companies - Europe Anti-Infective Agents Market

● Abbott

● Allergan Plc.

● Astellas Pharma Inc.

● Bayer AG

● Boehringer Ingelheim International GmbH

● Bristol-Myers Squibb Company

● F. Hoffmann-La Roche Ltd.

● Gilead Sciences, Inc.

● GlaxoSmithKline plc.

● Merck & Co., Inc.

● Novartis AG

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe anti-infective agents market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP